Processa Pharmaceuticals, Inc.

CIK: 1533743 SIC: 2834

Profile Charts Filings

Revenue

$-13.56M

Net Income

Gross Margin

Op. Margin

$-19.12M

Free Cash Flow

Financial Statements Annual (10-K)

Showing 12 of 12 annual reports available (2013 - 2025)

Show: 5 10 All (12)

Annual Quarterly

Breakdown	TTM (Dec 31, 2025)	FY 2025 (Dec 31, 2025)	FY 2024 (Dec 31, 2024)	FY 2023 (Dec 31, 2023)	FY 2022 (Dec 31, 2022)	FY 2021 (Dec 31, 2021)	FY 2020 (Dec 31, 2020)	FY 2019 (Dec 31, 2019)	FY 2017 (Dec 31, 2017)	FY 2016 (Dec 31, 2016)	FY 2015 (Dec 31, 2015)	FY 2014 (Dec 31, 2014)	FY 2013 (Dec 31, 2013)
+ Total Revenue	-	-	-	-	-	-	-	-	-	$5.00K	$113.42K	$200.20K	$312.48K
Revenue Growth %	nan%	nan%	nan%	nan%	nan%	nan%	nan%	nan%	nan%	-95.6%	-43.3%	-35.9%	nan%
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	$125.88K	$113.25K	$188.00K
+ Gross Profit	-	-	-	-	-	-	-	-	-	$5.00K	$-12.45K	$86.95K	$88.29K
Gross Margin %	nan%	nan%	nan%	nan%	nan%	nan%	nan%	nan%	nan%	100.0%	-11.0%	43.4%	28.3%
Operating Expenses	-	-	-	-	-	-	-	-	$1.80M	$76.53K	$2.68M	$4.25M	$3.09M
Research & Development	-	-	-	-	-	-	$3.17M	$2.32M	-	$6.56K	$29.25K	$189.75K	$267.06K
Selling General & Admin	-	-	-	-	-	-	-	-	-	$69.97K	$945.46K	$2.84M	$2.82M
+ Operating Income	$-13.99M	$-13.99M	$-12.05M	$-11.46M	$-27.53M	$-12.13M	$-15.14M	$-3.94M	$-1.80M	$-1.92M	-	-	-
Operating Margin %	nan%	nan%	nan%	nan%	nan%	nan%	nan%	nan%	nan%	-38430.4%	nan%	nan%	nan%
Interest Expense	$9.37K	$5.61K	$1.20K	-	-	$362.00	$281.12K	$36.66K	$59.06K	$245.38K	$235.64K	$-365.96K	$-109.72K
Interest Income	-	$109.49K	$201.09K	$335.54K	$101.20K	$11.99K	$3.17K	$11.55K	$5.18K	$4.45K	$4.65K	$249.00	$2.39K
Income Before Tax	-	$-13.56M	$-11.85M	$-11.12M	$-27.42M	$-11.96M	$-15.41M	$-3.96M	-	$-337.18K	$-2.98M	$-4.53M	$-3.07M
Income Tax Expense	-	-	-	-	-	$-530.61K	$-1.00M	$-602.72K	$258.58K	-	$-100.00	$-100.00	$-50.00
+ Net Income	$-13.56M	$-13.56M	$-11.85M	$-11.12M	$-27.42M	$-11.43M	$-14.41M	$-3.36M	$-1.86M	$-335.98K	$-3.35M	$-4.53M	$-3.07M
Net Margin %	nan%	nan%	nan%	nan%	nan%	nan%	nan%	nan%	nan%	-6719.6%	-2957.2%	-2260.9%	-982.0%
Basic EPS	nan	-10.36	-3.87	-8.48	-1.70	-0.75	nan	nan	nan	nan	nan	nan	nan
Diluted EPS	nan	-10.36	-3.87	-8.48	-34.05	nan	nan	nan	nan	nan	nan	nan	nan
Basic Shares Outstanding	-	1.3M	122K	1.3M	16.1M	15.3M	-	-	-	-	-	-	-
Diluted Shares Outstanding	-	1.3M	122K	1.3M	805K	-	-	-	-	-	-	-	-

Breakdown	FY 2025 (Dec 31, 2025)	FY 2024 (Dec 31, 2024)	FY 2023 (Dec 31, 2023)	FY 2022 (Dec 31, 2022)	FY 2021 (Dec 31, 2021)	FY 2020 (Dec 31, 2020)	FY 2019 (Dec 31, 2019)	FY 2017 (Dec 31, 2017)	FY 2016 (Dec 31, 2016)	FY 2015 (Dec 31, 2015)	FY 2014 (Dec 31, 2014)	FY 2013 (Dec 31, 2013)
Cash & Cash Equivalents	$5.54M	$1.19M	$4.71M	$6.50M	$16.50M	$15.42M	$691.54K	$2.85M	$3.24K	$2.09K	$21.23K	$186.86K
Accounts Receivable	-	-	-	-	-	-	-	-	-	-	$4.09K	$19.20K
Inventory	-	-	-	-	-	-	-	-	-	-	$222.02K	$228.26K
Other Current Assets	$133.92K	$687.83K	$926.30K	$1.88M	$1.76M	$554.71K	$315.61K	-	-	$47.72K	$131.86K	$80.39K
Total Current Assets	$5.67M	$1.88M	$5.63M	$8.39M	$18.33M	$16.20M	$1.01M	$2.95M	$3.24K	$104.16K	$379.21K	$514.71K
Property Plant & Equipment	$3.81K	$5.02K	$2.55K	-	-	$484.00	$8.93K	$25.82K	$22.39K	$159.00	$466.41K	$369.77K
Intangible Assets	-	-	-	-	$8.06M	$8.85M	$9.64M	-	-	-	-	-
Other Non-current Assets	-	-	$5.54K	$5.54K	$8.14M	$9.01M	$9.87M	$5.54K	$5.54K	-	-	-
Total Assets	$7.81M	$3.23M	$5.79M	$8.62M	$26.46M	$25.21M	$10.88M	$2.98M	$3.24K	$104.32K	$2.54M	$2.94M
Accounts Payable	$1.06M	$880.88K	$311.62K	$327.55K	$218.91K	$320.69K	$75.61K	$50.69K	$166.16K	$159.25K	$190.17K	$77.03K
Accrued Liabilities	$1.18M	$578.73K	$146.27K	$403.06K	$279.26K	$224.68K	$213.24K	$64.43K	$134.51K	$95.34K	$105.61K	$256.09K
Other Current Liabilities	-	-	$39.00	$51.00	-	-	-	-	-	-	-	-
Total Current Liabilities	$2.24M	$1.53M	$730.58K	$998.56K	$971.02K	$1.22M	$1.19M	$2.60M	$2.35M	$2.08M	$840.05K	$1.12M
Deferred Tax Liabilities	-	-	-	-	-	$530.61K	$1.53M	-	-	-	-	-
Total Liabilities	$2.24M	$1.53M	$797.48K	$1.15M	$978.40K	$2.27M	$2.87M	$2.61M	$2.35M	$2.08M	$1.33M	$1.27M
Common Stock	$257.00	$15.00	$129.00	$1.61K	$1.57K	$1.42K	$549.00	$3.53K	$1.10K	$1.10K	$1.09K	$808.00
Retained Earnings	$-100.78M	$-87.22M	$-75.37M	$-64.25M	$-36.82M	$-25.40M	$-10.98M	$-3.86M	$-15.25M	$-14.87M	$-12.91M	$-6.81M
Treasury Stock	$300.00K	$300.00K	$300.00K	$300.00K	-	-	-	-	-	-	-	-
Total Stockholders Equity	$5.58M	$1.70M	$4.99M	$7.47M	$25.49M	$22.94M	$8.01M	$373.16K	$-2.35M	$-1.98M	$1.21M	$1.67M
Total Liabilities & Equity	$7.81M	$3.23M	$5.79M	$8.62M	$26.46M	$25.21M	$10.88M	$2.98M	$3.24K	$104.32K	$2.54M	$2.94M

Breakdown	TTM (Dec 31, 2025)	FY 2025 (Dec 31, 2025)	FY 2024 (Dec 31, 2024)	FY 2023 (Dec 31, 2023)	FY 2022 (Dec 31, 2022)	FY 2021 (Dec 31, 2021)	FY 2020 (Dec 31, 2020)	FY 2019 (Dec 31, 2019)	FY 2017 (Dec 31, 2017)	FY 2016 (Dec 31, 2016)	FY 2015 (Dec 31, 2015)	FY 2014 (Dec 31, 2014)	FY 2013 (Dec 31, 2013)
Net Income	$-13.56M	$-13.56M	$-11.85M	$-11.12M	$-27.42M	$-11.43M	$-14.41M	$-3.36M	$-1.86M	$-335.98K	$-3.35M	$-4.53M	$-3.07M
Stock-based Compensation	$1.52M	$857.55K	$629.51K	$1.06M	$8.83M	$3.41M	$2.73M	$510.48K	-	$6.69K	$96.93K	$231.52K	$216.08K
Deferred Income Tax	-	-	-	-	-	$-530.61K	$-1.00M	$-602.72K	-	-	-	-	-
Change in Receivables	-	-	-	-	-	-	-	-	-	-	$-3.84K	$15.11K	$11.75K
Change in Inventory	-	-	-	-	-	-	-	-	-	-	$-7.07K	$-77.47K	$-97.37K
Change in Payables	$-247.53K	$175.92K	$569.26K	$-15.93K	$108.64K	$-101.79K	$245.08K	$-216.49K	$9.99K	$-10.34K	$5.32K	$84.40K	$3.86K
Operating Cash Flow	$-19.12M	$-11.39M	$-11.25M	$-8.06M	$-9.61M	$-8.72M	$-3.14M	$-2.75M	$-1.65M	$-43.20K	$-871.91K	$-2.70M	$-2.54M
Capital Expenditure	-	-	$3.24K	$2.78K	-	-	-	-	$20.62K	$23.77K	$1.40K	$48.30K	$27.67K
Investing Cash Flow	-	$-850.00K	$-3.24K	$-2.78K	-	-	-	-	$1.00M	$17.00K	$40.20K	$-44.94K	$-27.67K
Debt Repayment	-	-	-	-	-	-	-	-	-	-	$19.90K	$45.53K	$30.24K
Stock Issued	-	$16.60M	$7.76M	$6.32M	-	$10.05M	$17.10M	-	-	$4.27M	$88.00K	$366.32K	-
Stock Repurchased	-	-	-	-	$300.00K	-	-	-	-	-	-	-	-
Financing Cash Flow	$31.76M	$16.58M	$7.73M	$6.27M	$-388.84K	$9.80M	$17.87M	$1.70M	$2.43M	$15.00K	$821.10K	$2.57M	$1.73M
Net Change in Cash	$11.80M	$4.35M	$-3.51M	$-1.80M	$-9.99M	$1.08M	$14.72M	$-1.05M	$1.78M	$-11.20K	$-10.60K	$-165.63K	$-834.61K

SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025

Condensed Consolidated Statements of Operations

Description	Sep 30, 2025		Sep 30, 2025
Description	Current	Prior Year	Current YTD	Prior Year YTD
Operating Income	$-3.49M	-	$-10.29M	-
Interest Expense	-	-	$5.59K	-
Net Income	$-3.44M	$-3.01M	$-10.20M	-
Basic EPS	-0.07	-	-0.41	-
Diluted EPS	-0.07	-	-0.41	-
Basic Shares Outstanding	$47.53M	-	$24.84M	-
Diluted Shares Outstanding	$47.53M	-	$24.84M	-

Condensed Consolidated Balance Sheets

Description	Sep 30, 2025	Dec 31, 2024
Cash & Cash Equivalents	$6.31M	$1.19M
Other Current Assets	$278.34K	$687.83K
Total Current Assets	$6.59M	$1.88M
Property Plant & Equipment	$4.11K	$5.02K
Total Assets	$7.58M	$3.23M
Accounts Payable	$727.17K	$880.88K
Accrued Liabilities	$1.02M	$578.73K
Total Current Liabilities	$1.75M	$1.53M
Total Liabilities	$1.75M	$1.53M
Common Stock	$5.29K	$371.00
Retained Earnings	$-97.42M	$-87.22M
Treasury Stock	$300.00K	$300.00K
Total Stockholders Equity	$5.83M	$1.70M
Total Liabilities & Equity	$7.58M	$3.23M

Condensed Consolidated Statements of Cash Flows

Description	Sep 30, 2025		Sep 30, 2025
Description	Current	Prior Year	Current YTD	Prior Year YTD
Net Income	$-3.44M	$-3.01M	$-10.20M	-
Stock-based Compensation	-	-	$734.01K	-
Change in Payables	-	-	$-153.71K	-
Operating Cash Flow	-	-	$-8.48M	-
Investing Cash Flow	-	-	-	-
Financing Cash Flow	-	-	$13.60M	-
Net Change in Cash	-	-	$5.12M	-

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.